A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTI-CENTRE, PHASE III STUDY OF MLC901 (NEUROAID II™) FOR THE TREATMENT OF COGNITIVE IMPAIRMENT AFTER MILD TRAUMATIC BRAIN INJURY
Preprint in medRxiv (August 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Preprint in medRxiv (August 2024)
Preprint in Research Square (April 2024)
Preprint in Research Square (March 2024)